Back

Left atrial appendage occlusion: a viable alternative to oral anticoagulation

13 April 2026 (10:45 - 11:00)
Organised by: Logo
Congress Presentation Part of: Scanning the horizon: trials that will improve care of atrial fibrillation patients Atrial Fibrillation (AF) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Jeff Healey

Population Health Research Institute, Hamilton (Canada)

3 More presentations in this session

Presentation thumbnail
Early rhythm control: impact on patient outcome
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
AV nodal ablation and conduction system pacing
Professor Z. Whinnett (London, GB)
Slides Video
Presentation thumbnail
Navigating the 'ocean' of anticoagulation: optimising post-ablation management
Doctor A. Verma (Montreal, CA)
Slides Video

Access the full session

Session thumbnail
Scanning the horizon: trials that will improve care of atrial fibrillation patients
Video

The Event

Event poster

EHRA 2026

13 April 2026 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage occlusion should always be considered: con
20 February 2026
thumbnail
Congress Presentation
Insights into the latest clinical data
12 April 2026
thumbnail
Congress Presentation
What is the optimal anticoagulation/antiplatelet strategy following left atrial appendage closure?
12 April 2026
thumbnail
Congress Presentation
LAAOA-3: is surgical exclusion good enough?
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources